Finance

Lists
Why is 543748 up 2,38%?
Dive Deeper
543748:BOM
Aarti Pharmalabs Ltd
₹974,90
+2,38%
(+22,65) 1D
1 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543748...
Open
₹953,00
High
₹985,00
Low
₹922,00
Mkt. cap
88,54 mjd
Avg. vol.
47,22 k
Volume
28,06 k
Dividend
0,36%
Quarterly dividend
₹0,87
Ex-dividend date
15 Sep. 2026
P/E ratio
44,27
52-wk high
₹1 001,55
52-wk low
₹583,85
EPS
₹22,02
No. of employees
2 k
Open
₹953,00
High
₹985,00
Low
₹922,00
Mkt. cap
88,54 mjd
Avg. vol.
47,22 k
Volume
28,06 k
Dividend
0,36%
Quarterly dividend
₹0,87
Ex-dividend date
15 Sep. 2026
P/E ratio
44,27
52-wk high
₹1 001,55
52-wk low
₹583,85
EPS
₹22,02
No. of employees
2 k
News stories
From web sources and news partners
About Aarti Pharmalabs Ltd
CEO-
Employees2,42 k
Founded2019
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,18 mjd
4,32 mjd
5,83 mjd
5,36 mjd
Cost of goods sold
2,10 mjd
1,73 mjd
3,32 mjd
2,37 mjd
Cost of revenue
2,10 mjd
1,73 mjd
3,32 mjd
2,37 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
434,12 m
433,78 m
506,84 m
503,25 m
Operating expense
1,59 mjd
1,86 mjd
1,49 mjd
1,97 mjd
Total operating expenses
3,68 mjd
3,59 mjd
4,81 mjd
4,33 mjd
Operating income
499,50 m
736,91 m
1,02 mjd
1,03 mjd
Other non operating income
504,00 k
-3,71 m
63,33 m
4,53 m
EBT including unusual items
386,92 m
628,69 m
658,79 m
1,01 mjd
EBT excluding unusual items
386,92 m
656,64 m
658,79 m
1,01 mjd
Income tax expense
107,69 m
149,13 m
165,78 m
249,18 m
Effective tax rate
27,83%
23,72%
25,16%
24,66%
Other operating expenses
904,28 m
1,14 mjd
698,65 m
1,16 mjd
Net income
279,23 m
479,56 m
493,01 m
761,43 m
Net profit margin
6,67%
11,09%
8,46%
14,21%
Earnings per share
-
-
-
-
Interest and investment income
-
-
21,39 m
-
Interest expense
-106,65 m
-125,80 m
-168,63 m
-128,75 m
Net interest expenses
-106,65 m
-125,80 m
-147,24 m
-128,75 m
Depreciation and amortization charges
247,69 m
286,18 m
281,56 m
300,28 m
EBITDA
737,30 m
927,92 m
1,22 mjd
1,29 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme